Whereas the improper use of beta-agonists can be a serious risk to human health; whereas, in the interests of the consumer, the holding, administering to animals of any species and the placing on the market for that purpose of beta-agonists should be prohibited; whereas, moreover, the holding, administering to animals of any species and the placing on the market of stilbenes and thyrostatic substances should be prohibited and the use of other substances regulated;
Recital 6, Directive (EU) 1996/22
Judgment of the Court of 26 February 2002. Council of the European Union v Boehringer Ingelheim Vetmedica GmbH and C. H. Boehringer Sohn.Decision
According to the sixth recital in the preamble to Directive 96/22, the improper use of beta-agonists can be a serious risk to human health, so that, in the interests of the consumer, the holding, administering to animals of any species and …
26 Feb 2002 · 62000CJ0023
Judgment of the Court of 26 February 2002. Commission of the European Communities v Boehringer Ingelheim Vetmedica GmbH and C. H. BoehringerDecision
According to the sixth recital in the preamble to Directive 96/22, the improper use of beta-agonists can be a serious risk to human health, so that, in the interests of the consumer, the holding, administering to animals of any species and …
26 Feb 2002 · 62000CJ0032